For the year ending 2025-12-31, MIRM has $842,813K in assets. $528,123K in debts. $296,683K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 296,683 | |||
| Short-term investments | 86,644 | |||
| Accounts receivable | 123,330 | |||
| Inventory | 24,887 | |||
| Prepaid expenses and other current assets | 18,140 | |||
| Total current assets | 549,684 | |||
| Restricted cash | 1,482 | |||
| Long-term investments | 8,105 | |||
| Property and equipment, net | 1,862 | |||
| Operating lease right-of-use assets | 8,741 | |||
| Intangible assets, net | 260,921 | |||
| Other assets | 12,018 | |||
| Total assets | 842,813 | |||
| Accounts payable | 9,614 | |||
| Accrued expenses and other current liabilities | 196,185 | |||
| Total current liabilities | 205,799 | |||
| Operating lease liabilities, noncurrent | 7,516 | |||
| Convertible notes payable, net, noncurrent | 309,797 | |||
| Other liabilities | 5,011 | |||
| Total liabilities | 528,123 | |||
| Common stock, 0.0001 par value 200,000,000 shares authorized 51,896,391 and 48,338,096 shares issued and outstanding as of december31, 2025 and 2024, respectively | 5 | |||
| Additional paid-in capital | 981,878 | |||
| Accumulated deficit | -667,544 | |||
| Accumulated other comprehensive income (loss) | 351 | |||
| Total stockholders equity | 314,690 | |||
| Total liabilities and stockholders equity | 842,813 | |||
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)